BOTOX® 100u (onabotulinumtoxinA) is a purified botulinum toxin type A injectable used for both therapeutic and aesthetic applications to temporarily reduce muscle activity. Supplied as 1 sterile single-use vial containing 100 units, it acts as a neuromuscular blocking agent by inhibiting the release of acetylcholine at the neuromuscular junction. This mechanism allows for controlled muscle relaxation, making it suitable for the management of medical conditions as well as the treatment of dynamic facial wrinkles such as glabellar lines.
KEY FEATURES
BOTOX® 100u is a clinically proven formulation designed for precise, localized muscle modulation. By selectively targeting overactive or spastic muscles, it delivers predictable and controlled results while preserving surrounding muscle function.
The product is widely used across medical and aesthetic disciplines and is recognized for its consistency, reliability, and established safety profile when administered correctly.
BENEFITS
• Temporarily reduces muscle activity in targeted areas
• Provides precise, localized treatment effects
• Suitable for both therapeutic and cosmetic indications
• Long-lasting results, typically 12–16 weeks for medical use and up to 4 months for aesthetic treatments
• Trusted and extensively studied botulinum toxin formulation
USAGE INSTRUCTIONS
-
Reconstitute the vial using preservative-free 0.9% Sodium Chloride Injection (USP) according to the desired concentration.
-
Administer via intramuscular injection into the target muscles by a qualified healthcare professional.
-
Dosage and injection sites should be determined based on indication, muscle anatomy, and patient assessment.
For professional use only. Administration must be performed by a licensed and trained healthcare provider.
PACKAGING
• 1 sterile single-use vial
• 100 units of onabotulinumtoxinA
• Lyophilized powder for reconstitution
IDEAL FOR
• Cosmetic treatment of dynamic facial wrinkles, including glabellar lines
• Management of muscle spasticity
• Treatment of chronic migraine
• Overactive bladder and other approved therapeutic indications